01 Integration of Artificial Intelligence The incorporation of artificial intelligence into these devices is revolutionizing surgical practices by enhancing image analysis and supporting real-time decision-making. AI-driven algorithms can analyze vast datasets, providing surgeons with critical insights throughout procedures, leading to more accurate and effective outcomes. For example, Medtronic plc has developed the GI Genius Intelligent Endoscopy Module, the first AI-powered polyp detection system on the market. This advanced module has demonstrated a 14.4% increase in adenoma detection rates (ADR), significantly improving early diagnosis and patient safety. Innovative AI-enabled systems like these are enhancing patient safety and elevating standards in both diagnostics and surgical precision.
June 2026 Medtronic submitted U.S. FDA 510(k) applications to expand indications for its Hugo™ robotic-assisted surgery system into general and gynecologic surgery, broadening the platform's clinical applications in minimally invasive and endoscopic procedures.
October 2025 Intuitive Surgical received U.S. FDA clearance for a suite of AI-enabled software enhancements for its Ion Endoluminal System, improving navigation, imaging, and workflow efficiency for robotic-assisted lung biopsy procedures.
May 2025 Meril Life Sciences launched the MIZZO Endo 4000, an indigenously developed robotic soft-tissue surgery platform supporting gastrointestinal, urology, gynecology, and oncology procedures, expanding its robotic endoscopy and minimally invasive surgery portfolio.